1-(butyl)-3-((1H-benzo[d]1,2,3-triazol-1-yl)methyl)-1H-imidazol-3-ium chloride

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并三唑类
• 英文名称: 1-(butyl)-3-((1H-benzo[d]1,2,3-triazol-1-yl)methyl)-1H-imidazol-3-ium chloride
• 英文别名: 1-[(3-Butylimidazol-1-ium-1-yl)methyl]benzotriazole;chloride；1-[(3-butylimidazol-1-ium-1-yl)methyl]benzotriazole;chloride
• 化学式: C₁₄H₁₈N₅*Cl
• 分子量: 291.783
• InChiKey: MLVOKUNWVKCCRZ-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -1.17
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  39.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-(butyl)-3-((1H-benzo[d]1,2,3-triazol-1-yl)methyl)-1H-imidazol-3-ium chloride 、 silver(l) oxide 以 二氯甲烷 为溶剂， 反应 24.0h， 以70%的产率得到bis[1-(n-butyl)-3-((1H-benzo[d]1,2,3-triazole-1-yl)methyl)imidazole-2-ylidene]silver(I) dichloro argentate(I)
  参考文献：
  名称：

  Benzotriazole functionalized N-heterocyclic carbene–silver(I) complexes: Synthesis, cytotoxicity, antimicrobial, DNA binding, and molecular docking studies

  摘要：

  In this study, six [Ag(NHC)(2)](+)[AgCl2](-) type silver complexes were synthesized by the reaction of corresponding carbene precursor and Ag2O. One [Ag(NHC)(2)]+NO3- type complex was synthesized by the anion exchange reaction of corresponding silver-NHC and NaNO3. The synthesized complexes were characterized by H-1 NMR, C-13 NMR and IR spectroscopic methods, and elemental analysis. X-ray crystal structure of 5a was also reported. Cytotoxicities of all compounds were evaluated against human breast (MCF-7) and colorectal (Caco-2) cancer cell lines and non-cancer mouse fibroblast (L-929) cell lines. All complexes performed stronger activity against both cancer cell lines than standard compound cisplatin while complex 3b performed nearly equal cytotoxicity to cisplatin against non-cancer L-929. Antimicrobial effects of all compounds were evaluated against Escherichia coli, Bacillus subtilis and Candida albicans and good activities were observed. The docking results indicated that complex 3b might be classified as druggable molecule in drug design. DNA binding study also demonstrates that 3b complex has an interaction ability to DNA. Combination of experimental and molecular docking results revealed that reported complexes are promising structures and deserve further research as anticancer drugs. (C) 2018 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.poly.2018.06.052
• 作为产物：
  描述：

  N-丁基咪唑 、 1-(氯甲基)-1H-苯并三唑 以 N,N-二甲基甲酰胺 为溶剂， 反应 8.0h， 以94%的产率得到1-(butyl)-3-((1H-benzo[d]1,2,3-triazol-1-yl)methyl)-1H-imidazol-3-ium chloride
  参考文献：
  名称：

  功能化的咪唑鎓和苯并咪唑鎓盐作为对氧磷酶1抑制剂：合成，表征和分子对接研究

  摘要：

  对氧磷酶（PON）是活生物体代谢中的关键酶，PON1活性下降被认为是动脉粥样硬化和有机磷酸酯毒性的风险。本研究描述了功能化的咪唑鎓盐和苯并咪唑鎓盐（1a – 5g）的合成，表征，PON1抑制特性和分子对接研究。通过IR，NMR，元素分析来阐明所有化合物的结构，并通过单晶X射线衍射表征化合物2b和2c的结构。香豆素取代的咪唑鎓盐化合物1c对PON1的活性表现出最佳的抑制作用，IC 50良好值（6.37μM）。对该化合物的动力学研究进行了评估，结果表明该化合物是PON1的竞争性抑制剂，K i值为2.39μM。还对大多数活性化合物1c和最小活性化合物2c进行了分子对接研究，以确定可能的PON1活性位点结合模型并验证了实验结果。

  DOI：

  10.1016/j.bmc.2016.02.012

文献信息

• Palladium(II) and ruthenium(II) complexes of benzotriazole functionalized N-heterocyclic carbenes: Cytotoxicity, antimicrobial, and DNA interaction studies
  作者：Gülnihan Onar、Canbolat Gürses、Mert Olgun Karataş、Sevgi Balcıoğlu、Nuriye Akbay、Namık Özdemir、Burhan Ateş、Bülent Alıcı

  DOI：10.1016/j.jorganchem.2019.02.013

  日期：2019.4

  benzimidazole-based ruthenium complexes (3c and 3d) were found as non-cytotoxic against non-cancer L-929 cell lines while performing comparable cytotoxicity against Caco-2 cancer cell lines with cisplatin. In addition, DNA interaction studies were performed with pBR322 plasmid DNA and ctDNA and results showed that both palladium and ruthenium complexes have weaker ability to interact with DNA than cisplatin

  在本研究中，用苯并三唑取代的N-杂环卡宾配体合成了四个钯和四个钌配合物。配合物的结构通过适当的光谱方法和元素分析确定。此外，Pd NHC络合物的晶体结构（1c） 已经报道。研究了复合物的抗癌，抗微生物和DNA相互作用特性。测试了该复合物对两种细菌菌株和一种真菌菌株的抗菌作用。测试了该复合物对人乳腺癌（MCF-7）和结直肠癌（Caco-2）癌细胞系以及非癌性小鼠成纤维细胞（L-929）细胞系的细胞毒作用。发现钌复合物比钯复合物对癌细胞系的细胞毒性更大。特别地，发现含苄基的苯并咪唑基钌配合物（3c和3d）对非癌L-929细胞系无细胞毒性，同时对顺铂对Caco-2癌细胞系具有可比的细胞毒性。此外，使用pBR322质粒DNA和ct DNA和结果表明，与顺铂相比，钯和钌配合物与DNA相互作用的能力均较弱。这项研究的结果表明，尽管该配合物的细胞毒性不比顺铂强，但是含苄基苯并咪唑的钌-NHC复合物对Ca
• Functionalized imidazolium and benzimidazolium salts as paraoxonase 1 inhibitors: Synthesis, characterization and molecular docking studies
  作者：Mert Olgun Karataş、Harun Uslu、Bülent Alıcı、Başak Gökçe、Nahit Gencer、Oktay Arslan、N. Burcu Arslan、Namık Özdemir

  DOI：10.1016/j.bmc.2016.02.012

  日期：2016.3

  acknowledged as a risk for atherosclerosis and organophosphate toxicity. The present study describes the synthesis, characterization, PON1 inhibitory properties and molecular docking studies of functionalized imidazolium and benzimidazolium salts (1a–5g). The structures of all compounds were elucidated by IR, NMR, elemental analysis and structures of compounds 2b and 2c were characterized by single-crystal

  对氧磷酶（PON）是活生物体代谢中的关键酶，PON1活性下降被认为是动脉粥样硬化和有机磷酸酯毒性的风险。本研究描述了功能化的咪唑鎓盐和苯并咪唑鎓盐（1a – 5g）的合成，表征，PON1抑制特性和分子对接研究。通过IR，NMR，元素分析来阐明所有化合物的结构，并通过单晶X射线衍射表征化合物2b和2c的结构。香豆素取代的咪唑鎓盐化合物1c对PON1的活性表现出最佳的抑制作用，IC 50良好值（6.37μM）。对该化合物的动力学研究进行了评估，结果表明该化合物是PON1的竞争性抑制剂，K i值为2.39μM。还对大多数活性化合物1c和最小活性化合物2c进行了分子对接研究，以确定可能的PON1活性位点结合模型并验证了实验结果。
• Benzotriazole functionalized N-heterocyclic carbene–silver(I) complexes: Synthesis, cytotoxicity, antimicrobial, DNA binding, and molecular docking studies
  作者：Gülnihan Onar、Mert Olgun Karataş、Sevgi Balcıoğlu、Tuğba Taşkın Tok、Canbolat Gürses、Işın Kılıç-Cıkla、Namık Özdemir、Burhan Ateş、Bülent Alıcı

  DOI：10.1016/j.poly.2018.06.052

  日期：2018.10

  In this study, six [Ag(NHC)(2)](+)[AgCl2](-) type silver complexes were synthesized by the reaction of corresponding carbene precursor and Ag2O. One [Ag(NHC)(2)]+NO3- type complex was synthesized by the anion exchange reaction of corresponding silver-NHC and NaNO3. The synthesized complexes were characterized by H-1 NMR, C-13 NMR and IR spectroscopic methods, and elemental analysis. X-ray crystal structure of 5a was also reported. Cytotoxicities of all compounds were evaluated against human breast (MCF-7) and colorectal (Caco-2) cancer cell lines and non-cancer mouse fibroblast (L-929) cell lines. All complexes performed stronger activity against both cancer cell lines than standard compound cisplatin while complex 3b performed nearly equal cytotoxicity to cisplatin against non-cancer L-929. Antimicrobial effects of all compounds were evaluated against Escherichia coli, Bacillus subtilis and Candida albicans and good activities were observed. The docking results indicated that complex 3b might be classified as druggable molecule in drug design. DNA binding study also demonstrates that 3b complex has an interaction ability to DNA. Combination of experimental and molecular docking results revealed that reported complexes are promising structures and deserve further research as anticancer drugs. (C) 2018 Elsevier Ltd. All rights reserved.